Article
Galectin approach to lower covid transmission - Drug Development for clinical use
2022-11-10
Abstract excerpt
<h4>Background</h4> SARS-CoV-2 vaccines play an important role in reducing disease severity, hospitalization, and death, although they failed to prevent the transmission of SARS-CoV-2 variants. Therefore, an effective inhibitor of galectin-3 (Gal-3) could be used to treat and prevent transmission of COVID-19. ProLectin-M (PL-M), a Gal-3 antagonist, has been shown to interact with Gal-3 and thus prevent cellular en...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f60eba18-cb4f-5aa9-9a1f-28f4bb79471c
- DOI
- 10.1101/2022.11.09.22282151
